Concepedia
Statistics
Publications
22
Citations
1.4K
H-Index
16
Active since
1981
Affiliations
United States Food and Drug Administration(Current)
National Center for Toxicological Research
University of Michigan
ICF International (United States)
Medizinische Hochschule Hannover
Reagan Kelly is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and physiology.
Top concepts
MedicinePharmacologyHealthGeneticsCardiologyHepatologyPhysiologyBiochemistryHeart FailureDrug Discovery
Publications per year
1981–2022
A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure
Stephen B. Liggett, Sharon Cresci, Reagan Kelly et al. · Nature Medicine · 2008 · 320 citations · Full text
Molecular Pharmacology, Cardiomyopathy, Heart Failure +14
Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals.
Reagan Kelly, Robert D. Larsen, J G Bryant et al. · Proceedings of the National Academy of Sciences · 1994 · 190 citations · Full text
Immunohematology, Genetics, Blood Group Loci +18
Clinical and Genetic Modifiers of Long-Term Survival in Heart Failure
Sharon Cresci, Reagan Kelly, Thomas P. Cappola et al. · Journal of the American College of Cardiology · 2009 · 115 citations · Full text
Cardiomyopathy, Heart Failure, Cardiorenal Syndromes +10
Quantitative Structure-Activity Relationship Models for Predicting Drug-Induced Liver Injury Based on FDA-Approved Drug Labeling Annotation and Using a Large Collection of Drugs
Minjun Chen, Huixiao Hong, Hong Fang et al. · Toxicological Sciences · 2013 · 113 citations · Full text
Translating Clinical Findings into Knowledge in Drug Safety Evaluation - Drug Induced Liver Injury Prediction System (DILIps)
Zhichao Liu, Qiang Shi, Don Ding et al. · PLoS Computational Biology · 2011 · 96 citations · Full text
Drug Safety Evaluation, New Drug Candidates, Clinical Findings +20
1–5 of 22